Philippe Dartevelle

Philippe Dartevelle

Auto-generated profile, based on publicly available information

Philippe Dartevelle

Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Paris-Saclay University, 133 avenue de la Résistance, 92350, Le Plessis-Robinson, France.

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004
Verified
Journal Article
Open access
NGNazzareno Galiè
Nazzareno Galiè
ATAdam Torbicki
Adam Torbicki
RBRobyn Barst
Robyn Barst
PDPhilippe Dartevelle
Philippe Dartevelle
SHSheila Haworth
Sheila Haworth
GSGerald Simonneau
Gerald Simonneau

27 March 2017 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
PDP. G. Dartevelle
P. G. Dartevelle
DMD. Mitilian
D. Mitilian
EFE. Fadel
E. Fadel

15 January 2013 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
VMVincent de Montpreville
Vincent de Montpreville
MGMaria-Rosa Ghigna
Maria-Rosa Ghigna
LLLudovic Lacroix
Ludovic Lacroix
BBBenjamin Besse
Benjamin Besse
PBPhilippe Broet
Philippe Broet
PDPeter Dorfmuller
Peter Dorfmuller

15 July 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MRMathieu Rouanne
Mathieu Rouanne
JAJulien Adam
Julien Adam
AGAïcha Goubar
Aïcha Goubar
ARAngélique Robin
Angélique Robin
COCaroline Ohana
Caroline Ohana
JSJean-Charles Soria
Jean-Charles Soria
Osteopontin (OPN) and thrombospondin-1 (TSP-1) are extracellular matrix proteins secreted by stromal and tumor cells. These proteins appear to have a key role in the tumor microenvironment for cancer development and metastasis. There is little information regarding the prognostic value of the combination of these two proteins in human cancers. Our aim was to clarify clinical significance and prognostic value of each circulating protein and their combination in primary resected non-small cell lung cancer (NSCLC) patients. We retrospectively reviewed 171 patients with NSCLC following curative intent surgery from January to December of 2012. Preoperative serums, demographics, clinical and pathological data and molecular profiling were analyzed. Pre-treatment OPN and TSP-1 serum levels were measured by ELISA. Tissue protein expression in primary tumor samples was determined by immunohistochemical analysis. OPN and TSP-1 serum levels were inversely correlated with survival rates. For each 50 units increment of serum OPN, an increased risk of metastasis by 69 % (unadjusted HR 1.69, 95 % CI 1.12–2.56, p = 0.01) and an increased risk of death by 95 % (unadjusted HR 1.95, 95 % CI 1.15–3.32, p = 0.01) were observed. Conversely, for each 10 units increment in TSP-1, the risk of death was decreased by 85 % (unadjusted HR 0.15, 95 % CI 0.03–0.89; p = 0.04). No statistically significant correlation was found between TSP-1 serum level and distant metastasis-free survival (p = 0.2). On multivariate analysis, OPN and TSP-1 serum levels were independent prognostic factors of overall survival (HR 1.71, 95 % CI 1.04–2.82, p = 0.04 for an increase of 50 ng/mL in OPN; HR 0.18, 95 % CI 0.04–0.87, p = 0.03 for an increase of 10 ng/mL in TSP-1). In addition, the combination of OPN and TSP-1 serum levels remained an independent prognostic factor for overall survival (HR 1.31, 95 % CI 1.03–1.67, p = 0.03 for an increase of 6 ng/mL in OPN/TSP-1 ratio). Our results show that pre-treatment OPN and TSP-1 serum levels may reflect the aggressiveness of the tumor and might serve as prognostic markers in patients with primary resected NSCLC.

12 February 2008 in Respiratory Research
Verified
Journal Article
Open access
PDF file
ESEdouard Sage
Edouard Sage
OMOlaf Mercier
Olaf Mercier
FEFrederic Van Den Eyden
Frederic Van Den Eyden
MPMarc de Perrot
Marc de Perrot
ABAnne Marie Barlier-Mur
Anne Marie Barlier-Mur
EFElie Fadel
Elie Fadel
Endothelial dysfunction is a major complication of pulmonary endarterectomy (PTE) that can lead to pulmonary edema and persistent pulmonary hypertension. We hypothesized that endothelial dysfunction is related to increased endothelial-cell (EC) death.

30 September 2010 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
OMOlaf Mercier
Olaf Mercier
ESEdouard Sage
Edouard Sage
MIMohammed Izziki
Mohammed Izziki
MHMarc Humbert
Marc Humbert
PDPhilippe Dartevelle
Philippe Dartevelle
EFElie Fadel
Elie Fadel